0 534

Cited 5 times in

Survival Advantage of Icodextrin Peritoneal Dialysis Solution in a Time-Dependent Model

DC Field Value Language
dc.contributor.author한승혁-
dc.date.accessioned2014-12-18T08:22:05Z-
dc.date.available2014-12-18T08:22:05Z-
dc.date.issued2013-
dc.identifier.issn0272-6386-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/86175-
dc.description.abstractThe importance of immortal time in observational studies that have time-dependent treatment effects has been re-emphasized recently.1 The widespread use of advanced (physiologic pH, biocompatible bicarbonate/lactate-buffered) peritoneal dialysis solution in Korea has permitted the development of observational data sets that have been used to study the impact of these solutions on patient mortality. In our previous study, which used a data set of 2,163 patients enrolled from 54 Korean centers, we observed a significant association between improved patient survival and use of an advanced peritoneal dialysis solution.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfAMERICAN JOURNAL OF KIDNEY DISEASES-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHFemale-
dc.subject.MESHGlucans/therapeutic use*-
dc.subject.MESHGlucose/therapeutic use*-
dc.subject.MESHHemodialysis Solutions/therapeutic use*-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHPeritoneal Dialysis*-
dc.subject.MESHProportional Hazards Models-
dc.subject.MESHSurvival Rate-
dc.subject.MESHTime Factors-
dc.titleSurvival Advantage of Icodextrin Peritoneal Dialysis Solution in a Time-Dependent Model-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorSong Vogue Ahn-
dc.contributor.googleauthorEdward Vonesh-
dc.contributor.googleauthorSeung Hyeok Han-
dc.identifier.doi10.1053/j.ajkd.2012.10.007-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA04304-
dc.relation.journalcodeJ00089-
dc.identifier.eissn1523-6838-
dc.identifier.pmid23157934-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0272638612013273-
dc.subject.keywordFemale-
dc.subject.keywordGlucans/therapeutic use*-
dc.subject.keywordGlucose/therapeutic use*-
dc.subject.keywordHemodialysis Solutions/therapeutic use*-
dc.subject.keywordHumans-
dc.subject.keywordMale-
dc.subject.keywordPeritoneal Dialysis*-
dc.subject.keywordProportional Hazards Models-
dc.subject.keywordSurvival Rate-
dc.subject.keywordTime Factors-
dc.contributor.alternativeNameHan, Seung Hyeok-
dc.contributor.affiliatedAuthorHan, Seung Hyeok-
dc.rights.accessRightsnot free-
dc.citation.volume61-
dc.citation.number2-
dc.citation.startPage351-
dc.citation.endPage352-
dc.identifier.bibliographicCitationAMERICAN JOURNAL OF KIDNEY DISEASES, Vol.61(2) : 351-352, 2013-
dc.identifier.rimsid28831-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.